In renal cell carcinoma, the expression of macrophage markers (CD163, CD203, CD206) in mass cytometry with antibody panels was associated with an increased expression of PD-1 on CD8+ T cells, which suggest a direct interplay of myeloid and lymphoid cell lines in tumor progression and may serve as a common therapeutic target (25). This evidence concerns the gene PDCD1 and neoplasm.